» Articles » PMID: 34290295

Characterization and Visualization of Murine Coagulation Factor VIII-producing Cells in Vivo

Overview
Journal Sci Rep
Specialty Science
Date 2021 Jul 22
PMID 34290295
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Coagulation factors are produced from hepatocytes, whereas production of coagulation factor VIII (FVIII) from primary tissues and cell species is still controversial. Here, we tried to characterize primary FVIII-producing organ and cell species using genetically engineered mice, in which enhanced green fluorescent protein (EGFP) was expressed instead of the F8 gene. EGFP-positive FVIII-producing cells existed only in thin sinusoidal layer of the liver and characterized as CD31, CD146, and lymphatic vascular endothelial hyaluronan receptor 1 (Lyve1). EGFP-positive cells can be clearly distinguished from lymphatic endothelial cells in the expression profile of the podoplanin and C-type lectin-like receptor-2 (CLEC-2). In embryogenesis, EGFP-positive cells began to emerge at E14.5 and subsequently increased according to liver maturation. Furthermore, plasma FVIII could be abolished by crossing F8 conditional deficient mice with Lyve1-Cre mice. In conclusion, in mice, FVIII is only produced from endothelial cells exhibiting CD31, CD146, Lyve1, CLEC-2, and podoplanin in liver sinusoidal endothelial cells.

Citing Articles

Rescue of the endogenous FVIII expression in hemophilia A mice using CRISPR-Cas9 mRNA LNPs.

Chen C, Cai X, Konkle B, Miao C Mol Ther Nucleic Acids. 2024; 35(4):102383.

PMID: 39640016 PMC: 11617921. DOI: 10.1016/j.omtn.2024.102383.


Efficient generation of liver sinusoidal endothelial-like cells secreting coagulation factor VIII from human induced pluripotent stem cells.

Mitani S, Hosoda C, Onodera Y, Takabayashi Y, Sakata A, Shima M Mol Ther Methods Clin Dev. 2024; 32(4):101355.

PMID: 39559558 PMC: 11570519. DOI: 10.1016/j.omtm.2024.101355.


Discovery of Transcription Factors Involved in the Maintenance of Resident Vascular Endothelial Stem Cell Properties.

Konishi H, Rahmawati F, Okamoto N, Akuta K, Inukai K, Jia W Mol Cell Biol. 2024; 44(1):17-26.

PMID: 38247234 PMC: 10829836. DOI: 10.1080/10985549.2023.2297997.


Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A.

Hiramoto T, Inaba H, Baatartsogt N, Kashiwakura Y, Hayakawa M, Kamoshita N Blood Adv. 2023; 7(22):7017-7027.

PMID: 37792826 PMC: 10690555. DOI: 10.1182/bloodadvances.2023010838.


Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.

Gong J, Yang R, Zhou M, Chang L Mol Med. 2023; 29(1):74.

PMID: 37308845 PMC: 10262495. DOI: 10.1186/s10020-023-00680-z.


References
1.
Ohmori T, Mizukami H, Ozawa K, Sakata Y, Nishimura S . New approaches to gene and cell therapy for hemophilia. J Thromb Haemost. 2015; 13 Suppl 1:S133-42. DOI: 10.1111/jth.12926. View

2.
Everett L, Cleuren A, Khoriaty R, Ginsburg D . Murine coagulation factor VIII is synthesized in endothelial cells. Blood. 2014; 123(24):3697-705. PMC: 4055920. DOI: 10.1182/blood-2014-02-554501. View

3.
Kisanuki Y, Hammer R, Miyazaki J, Williams S, Richardson J, Yanagisawa M . Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol. 2001; 230(2):230-42. DOI: 10.1006/dbio.2000.0106. View

4.
Postic C, Magnuson M . DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis. 2000; 26(2):149-50. DOI: 10.1002/(sici)1526-968x(200002)26:2<149::aid-gene16>3.0.co;2-v. View

5.
Si-Tayeb K, Lemaigre F, Duncan S . Organogenesis and development of the liver. Dev Cell. 2010; 18(2):175-89. DOI: 10.1016/j.devcel.2010.01.011. View